摘要
目的观察前列地尔联合倍他司汀治疗椎-基底动脉供血不足的临床疗效。方法将136例椎-基底动脉供血不足患者随机分为前列地尔联合倍他司汀治疗组(68例)和倍他司汀对照组(68例),观察临床疗效及治疗前后椎-基底动脉平均血流速度的改善情况。结果治疗组治愈率及总有效率高于对照组(P<0.05);治疗组各动脉平均血流速度均明显较对照组改善(P<0.05)。结论前列地尔联合倍他司汀治疗椎-基底动脉供血不足疗效显著。
Objective To observe the clinical efficacy of alprostadil combined with betahistine in treating vertebral-basilar artery insufficiency.Methods 136 patients with vertebral-basilar artery insufficiency were randomly divided into alprostadil combined with betahistine treatment group（68 cases） and betahistine control group（68 cases）,clinical efficacy and the improvement of vertebral-basilar artery mean blood flow rate was observed before and after treatment.Results The cure rate and total effective rate of treatment group were higher（P0.05）;Artery mean blood flow velocity of treatment group were improved significantly than that in control group（P0.05）.Conclusion It is effective to treat the vertebral-basilar artery insufficiency with alprostadil combined with betahistine.
出处
《临床军医杂志》
CAS
2011年第2期244-245,共2页
Clinical Journal of Medical Officers
